Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Goodwill & Intangibles: 2023-2025

Historic Goodwill & Intangibles for Cartesian Therapeutics (RNAC) over the last 2 years, with Sep 2025 value amounting to $198.8 million.

  • Cartesian Therapeutics' Goodwill & Intangibles changed negligibly% to $198.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $198.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Cartesian Therapeutics' Goodwill & Intangibles stood at $198.8 million, which was down 0.00% from $198.8 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Goodwill & Intangibles ranged from a high of $198.8 million in Q4 2023 and a low of $198.8 million during Q4 2023.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $198.8 million (2025), whereas its average is $198.8 million.